Table 8.
Group | Dose (g/kg) | TLR-4 | MyD88 | NF-κB P65 |
---|---|---|---|---|
Control | - | 1083 ± 71 | 1017 ± 82 | 1035 ± 96 |
CP model | - | 9161 ± 353** | 9377 ± 328** | 9139 ± 327** |
FFZJF aerosol | 2.33 | 7882 ± 329**##Δ | 7174 ± 360**##Δ | 6427 ± 307**##Δ |
4.66 | 5854 ± 246**##Δ | 5654 ± 329**##Δ | 4970 ± 340**##Δ | |
9.32 | 3750 ± 260**##Δ | 3710 ± 203**## | 3768 ± 200**## | |
Ampicillin sodium | 0.93 | 3080 ± 310**## | 2729 ± 201**## | 3492 ± 418**## |
Notes: As compared to treated non-CP control group: *p < 0.05, **p < 0.01; as compared to treated CP model group: #p < 0.05, ##p < 0.01; as compared to treated Ampicillin sodium group: ΔP<0.05.